Epstein-Barr Virus SM Protein Utilizes Cellular Splicing Factor SRp20 to Mediate Alternative Splicing

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2010 Sep 3

PMID 20810723

Citations 40

Authors

Dinesh Verma

Swarna Bais

Melusine Gaillard

Sankar Swaminathan

Affiliations

Soon will be listed here.

Abstract

Epstein-Barr virus (EBV) SM protein is an essential nuclear protein produced during the lytic cycle of EBV replication. SM is an RNA-binding protein with multiple mechanisms of action. SM enhances the expression of EBV genes by stabilizing mRNA and facilitating nuclear export. SM also influences splicing of both EBV and cellular pre-mRNAs. SM modulates splice site selection of the host cell STAT1 pre-mRNA, directing utilization of a novel 5' splice site that is used only in the presence of SM. SM activates splicing in the manner of SR proteins but does not contain the canonical RS domains typical of cellular splicing factors. Affinity purification and mass spectrometry of SM complexes from SM-transfected cells led to the identification of the cellular SR splicing factor SRp20 as an SM-interacting protein. The regions of SM and SRp20 required for interaction were mapped by in vitro and in vivo assays. The SRp20 interaction was shown to be important for the effects of SM on alternative splicing by the use of STAT1 splicing assays. Overexpression of SRp20 enhanced SM-mediated alternative splicing and knockdown of SRp20 inhibited the SM effect on splicing. These data suggest a model whereby SM, a viral protein, recruits and co-opts the function of cellular SRp20 in alternative splicing.

Citing Articles

Identifying the key regulators orchestrating Epstein-Barr virus reactivation.

Wang Y, Yu J, Pei Y Front Microbiol. 2024; 15:1505191.

PMID: 39703703 PMC: 11655498. DOI: 10.3389/fmicb.2024.1505191.

Epstein-Barr virus induces host shutoff extensively via BGLF5-independent mechanisms.

Casco A, Ohashi M, Johannsen E Cell Rep. 2024; 43(10):114743.

PMID: 39298313 PMC: 11549945. DOI: 10.1016/j.celrep.2024.114743.

SARS-CoV-2 Selectively Induces the Expression of Unproductive Splicing Isoforms of Interferon, Class I MHC, and Splicing Machinery Genes.

Dias T, Mamede I, de Toledo N, Queiroz L, Castro I, Polidoro R Int J Mol Sci. 2024; 25(11).

PMID: 38891862 PMC: 11172111. DOI: 10.3390/ijms25115671.

Variant- and vaccination-specific alternative splicing profiles in SARS-CoV-2 infections.

Lee S, Furth P, Hennighausen L, Lee H iScience. 2024; 27(3):109177.

PMID: 38414855 PMC: 10897911. DOI: 10.1016/j.isci.2024.109177.

Variant- and Vaccination-Specific Alternative Splicing Profiles in SARS-CoV-2 Infections.

Lee S, Furth P, Hennighausen L, Lee H bioRxiv. 2023; .

PMID: 38076812 PMC: 10705549. DOI: 10.1101/2023.11.24.568603.

References

Walter M, Look D, Tidwell R, Roswit W, Holtzman M . Targeted inhibition of interferon-gamma-dependent intercellular adhesion molecule-1 (ICAM-1) expression using dominant-negative Stat1. J Biol Chem. 1997; 272(45):28582-9. DOI: 10.1074/jbc.272.45.28582. View

Gruffat H, Batisse J, Pich D, Neuhierl B, Manet E, Hammerschmidt W . Epstein-Barr virus mRNA export factor EB2 is essential for production of infectious virus. J Virol. 2002; 76(19):9635-44. PMC: 136519. DOI: 10.1128/jvi.76.19.9635-9644.2002. View

Buisson M, Hans F, Kusters I, Duran N, Sergeant A . The C-terminal region but not the Arg-X-Pro repeat of Epstein-Barr virus protein EB2 is required for its effect on RNA splicing and transport. J Virol. 1999; 73(5):4090-100. PMC: 104188. DOI: 10.1128/JVI.73.5.4090-4100.1999. View

Ruvolo V, Navarro L, Sample C, David M, Sung S, Swaminathan S . The Epstein-Barr virus SM protein induces STAT1 and interferon-stimulated gene expression. J Virol. 2003; 77(6):3690-701. PMC: 149524. DOI: 10.1128/jvi.77.6.3690-3701.2003. View

Key S, Yoshizaki T, Pagano J . The Epstein-Barr virus (EBV) SM protein enhances pre-mRNA processing of the EBV DNA polymerase transcript. J Virol. 1998; 72(11):8485-92. PMC: 110257. DOI: 10.1128/JVI.72.11.8485-8492.1998. View

Farjot G, Buisson M, Duc Dodon M, GAZZOLO L, Sergeant A, Mikaelian I . Epstein-Barr virus EB2 protein exports unspliced RNA via a Crm-1-independent pathway. J Virol. 2000; 74(13):6068-76. PMC: 112105. DOI: 10.1128/jvi.74.13.6068-6076.2000. View

Han Z, Verma D, Hilscher C, Dittmer D, Swaminathan S . General and target-specific RNA binding properties of Epstein-Barr virus SM posttranscriptional regulatory protein. J Virol. 2009; 83(22):11635-44. PMC: 2772688. DOI: 10.1128/JVI.01483-09. View

Verma D, Ling C, Johannsen E, Nagaraja T, Swaminathan S . Negative autoregulation of Epstein-Barr virus (EBV) replicative gene expression by EBV SM protein. J Virol. 2009; 83(16):8041-50. PMC: 2715772. DOI: 10.1128/JVI.00382-09. View

Johnson J, Castle J, Garrett-Engele P, Kan Z, Loerch P, Armour C . Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science. 2003; 302(5653):2141-4. DOI: 10.1126/science.1090100. View

10.

Graham F, Smiley J, Russell W, Nairn R . Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 1977; 36(1):59-74. DOI: 10.1099/0022-1317-36-1-59. View

11.

Zeghouf M, Li J, Butland G, Borkowska A, Canadien V, Richards D . Sequential Peptide Affinity (SPA) system for the identification of mammalian and bacterial protein complexes. J Proteome Res. 2004; 3(3):463-8. DOI: 10.1021/pr034084x. View

12.

Sahin B, Patel D, Conrad N . Kaposi's sarcoma-associated herpesvirus ORF57 protein binds and protects a nuclear noncoding RNA from cellular RNA decay pathways. PLoS Pathog. 2010; 6(3):e1000799. PMC: 2832700. DOI: 10.1371/journal.ppat.1000799. View

13.

Chen M, Manley J . Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol. 2009; 10(11):741-54. PMC: 2958924. DOI: 10.1038/nrm2777. View

14.

Sapra A, Anko M, Grishina I, Lorenz M, Pabis M, Poser I . SR protein family members display diverse activities in the formation of nascent and mature mRNPs in vivo. Mol Cell. 2009; 34(2):179-90. DOI: 10.1016/j.molcel.2009.02.031. View

15.

Ruvolo V, Gupta A, Swaminathan S . Epstein-Barr virus SM protein interacts with mRNA in vivo and mediates a gene-specific increase in cytoplasmic mRNA. J Virol. 2001; 75(13):6033-41. PMC: 114319. DOI: 10.1128/JVI.75.13.6033-6041.2001. View

16.

Ruvolo V, Wang E, Boyle S, Swaminathan S . The Epstein-Barr virus nuclear protein SM is both a post-transcriptional inhibitor and activator of gene expression. Proc Natl Acad Sci U S A. 1998; 95(15):8852-7. PMC: 21166. DOI: 10.1073/pnas.95.15.8852. View

17.

RABSON M, Gradoville L, Heston L, Miller G . Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye. J Virol. 1982; 44(3):834-44. PMC: 256340. DOI: 10.1128/JVI.44.3.834-844.1982. View

18.

Shen H, Green M . RS domain-splicing signal interactions in splicing of U12-type and U2-type introns. Nat Struct Mol Biol. 2007; 14(7):597-603. DOI: 10.1038/nsmb1263. View

19.

Ning Q, Berger L, Luo X, Yan W, Gong F, Dennis J . STAT1 and STAT3 alpha/beta splice form activation predicts host responses in mouse hepatitis virus type 3 infection. J Med Virol. 2003; 69(3):306-12. DOI: 10.1002/jmv.10290. View

20.

Baran-Marszak F, Feuillard J, Najjar I, Le Clorennec C, Bechet J, Dusanter-Fourt I . Differential roles of STAT1alpha and STAT1beta in fludarabine-induced cell cycle arrest and apoptosis in human B cells. Blood. 2004; 104(8):2475-83. DOI: 10.1182/blood-2003-10-3508. View